Fennec Pharmaceuticals (FENC) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to $21.9 million.
- Fennec Pharmaceuticals' Cash & Current Investments fell 4556.8% to $21.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.9 million, marking a year-over-year decrease of 4556.8%. This contributed to the annual value of $26.6 million for FY2024, which is 10072.35% up from last year.
- As of Q3 2025, Fennec Pharmaceuticals' Cash & Current Investments stood at $21.9 million, which was down 4556.8% from $18.7 million recorded in Q2 2025.
- Fennec Pharmaceuticals' 5-year Cash & Current Investments high stood at $51.2 million for Q1 2024, and its period low was $12.4 million during Q3 2023.
- In the last 5 years, Fennec Pharmaceuticals' Cash & Current Investments had a median value of $23.2 million in 2022 and averaged $24.6 million.
- In the last 5 years, Fennec Pharmaceuticals' Cash & Current Investments crashed by 5832.55% in 2023 and then surged by 28574.12% in 2024.
- Fennec Pharmaceuticals' Cash & Current Investments (Quarter) stood at $24.3 million in 2021, then fell by 2.31% to $23.8 million in 2022, then plummeted by 44.19% to $13.3 million in 2023, then surged by 100.72% to $26.6 million in 2024, then fell by 17.6% to $21.9 million in 2025.
- Its last three reported values are $21.9 million in Q3 2025, $18.7 million for Q2 2025, and $22.7 million during Q1 2025.